Scientists have discovered a novel way by which a much-studied cancer-promoting gene accelerates the disease. The finding suggests a new strategy to halt cancer’s progress.

Faculty are invited to submit an application for the next round of funding by March 2 in the Resource Allocation Program.

With support from the Fogarty International Center, the UCSF School of Nursing is examining the impact of stigma as it relates to nurses who care for HIV patients in developing countries.

The rate of sudden deaths increased six-fold in the first year that California law enforcement agencies deployed the use of stun guns, according to a UCSF study. Findings also showed a two-fold increase in the rate of firearm-related deaths during the same time period.

Scientists at UCSF have discovered an abnormality in a patient’s immune system that may lead to safer therapies for autoimmune diseases such as rheumatoid arthritis and colitis, as well as potential new ways to treat transplant rejection.

Drug side effects have been sidelining already-approved drugs. New inventions by Laurence Tecott, MD, PhD, and Evan Goulding, MD, PhD, allow monitoring of complex mouse behaviors and may yield early warnings of possible pharmaceutical side effects. Big Pharma and biotech drug development should benefit as a result.

MicroRNA inhibitors of genes reveal their targets in a UCSF Kaposi’s sarcoma study. Howard Hughes Medical Institute investigator Don Ganem leads efforts to find guiding principles that will point to the targets of microRNA in health and disease.